Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo

Por Barton, Valerie N., D’Amato, Nicholas C., Gordon, Michael A., Lind, Hanne T., Spoelstra, Nicole S., Babbs, Beatrice L., Heinz, Richard E., Elias, Anthony, Jedlicka, Paul, Jacobsen, Britta M., Richer, Jennifer K.
Publicado no Mol Cancer Ther (2015)

A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer

Por D’Amato, Nicholas C., Rogers, Thomas J., Gordon, Michael A., Greene, Lisa I., Cochrane, Dawn R., Spoelstra, Nicole S., Nemkov, Travis G., D’Alessandro, Angelo, Hansen, Kirk C., Richer, Jennifer K.
Publicado no Cancer Res (2015)

Cooperative Dynamics of AR and ER Activity in Breast Cancer

Por D’Amato, Nicholas C., Gordon, Michael A., Babbs, Beatrice L., Spoelstra, Nicole S., Carson Butterfield, Kiel T., Torkko, Kathleen C., Phan, Vernon T., Barton, Valerie N., Rogers, Thomas J., Sartorius, Carol A, Elias, Anthony D., Gertz, Jason, Jacobsen, Britta M., Richer, Jennifer K.
Publicado no Mol Cancer Res (2016)

Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System

Por D’Amato, Nicholas C., Ostrander, Julie H., Bowie, Michelle L., Sistrunk, Christopher, Borowsky, Alexander, Cardiff, Robert D., Bell, Katie, Young, Lawrence J. T., Simin, Karl, Bachelder, Robin E., Delrow, Jeff, Dawson, Alyssa, Yee, Lisa D., Mrózek, Krzysztof, Clay, Timothy M., Osada, Takuya, Seewaldt, Victoria L.
Publicado em 2012

ESR1 Promoter Hypermethylation Does Not Predict Atypia in RPFNA nor Persistent Atypia after 12 Months Tamoxifen Chemoprevention

Por Baker, Joseph C., Ostrander, Julie H., Lem, Siya, Broadwater, Gloria, Bean, Gregory R., D'Amato, Nicholas C., Goldenberg, Vanessa K., Rowell, Craig, Ibarra-Drendall, Catherine, Grant, Tracey, Pilie, Patrick G., Vasilatos, Shauna N., Troch, Michelle M., Scott, Victoria, Wilke, Lee G., Paisie, Carolyn, Rabiner, Sarah M., Torres-Hernandez, Alejandro, Zalles, Carola M., Seewaldt, Victoria L.
Publicado em 2008

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

Por Cochrane, Dawn R, Bernales, Sebastián, Jacobsen, Britta M, Cittelly, Diana M, Howe, Erin N, D’Amato, Nicholas C, Spoelstra, Nicole S, Edgerton, Susan M, Jean, Annie, Guerrero, Javier, Gómez, Francisco, Medicherla, Satyanarayana, Alfaro, Iván E, McCullagh, Emma, Jedlicka, Paul, Torkko, Kathleen C, Thor, Ann D, Elias, Anthony D, Protter, Andrew A, Richer, Jennifer K
Publicado em 2014

CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis

Por Vasilatos, Shauna N., Broadwater, Gloria, Barry, William T., Baker, Joseph C., Lem, Siya, Dietze, Eric C., Bean, Gregory R., Bryson, Andrew D., Pilie, Patrick G., Goldenberg, Vanessa, Skaar, David, Paisie, Carolyn, Torres-Hernandez, Alejandro, Grant, Tracey L., Wilke, Lee G., Ibarra-Drendall, Catherine, Ostrander, Julie H., D'Amato, Nicholas C., Zalles, Carola, Jirtle, Randy, Weaver, Valerie M., Seewaldt, Victoria L.
Publicado em 2009